Laurus Labs Ltd.

As of June 30, 2026, Laurus Labs Ltd. carries a market capitalization of 819.77B, placing it among publicly traded companies globally. Its enterprise value stands at 819.77B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Laurus Labs Ltd.'s next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Laurus Labs Ltd. has 540.25M shares outstanding.

As of June 30, 2026, Laurus Labs Ltd. trades at a trailing price-to-earnings ratio of 77.14.

As of June 30, 2026, Laurus Labs Ltd. trades at an EV/EBITDA multiple of 40.73 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 11.41 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 53.60 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 819.77B versus a market cap of 819.77B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 5.46M in revenue per employee across its workforce of 13,149.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Laurus Labs Ltd. recorded 3.35B in income tax expense. That works out to an effective tax rate of 24.07, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 13.94B, leaving 10.61B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Laurus Labs Ltd.'s stock has gained approximately 110.83% over the past 52 weeks. The 50-day moving average sits at 1,943.47, while the 200-day moving average is 1,421.65.

Over the twelve months ended June 30, 2026, Laurus Labs Ltd. generated 71.86B in revenue and converted that into 10.61B in net income, yielding earnings per share of 19.57. EBITDA reached 20.13B, while operating income came in at 15.29B.

Over the twelve months ended June 30, 2026, Laurus Labs Ltd. posted a gross margin of 61.20, reflecting its pricing power and cost economics. The operating margin of 21.28 and net profit margin of 14.77 provide insight into operational efficiency.

Laurus Labs Ltd.'s most recent stock split took place on September 29, 2020 with a 1:5 split ratio.